Document is current
Any future updates will be listed below
-
Authors
Diricks, Margo
Maurer, Florian P.
Dreyer, Viola
Barilar, Ivan
Utpatel, Christian
Merker, Matthias
Wetzstein, Nils
Niemann, Stefan
-
Funding
Funding for this research was provided by:
German Cystic Fibrosis Association Mukoviszidose e.V (2004)
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germanys Excellence Strategy Precision Medicine in Inflammation (EXC 2167)
Forschungszentrum Borstel - Leibniz Lungenzentrum
- License Information
-
More Information
Article History
Received: 22 October 2024
Accepted: 21 February 2025
First Online: 4 March 2025
Declarations
:
: Not applicable.
: Not applicable.
: MD, NW, IB, VD, CU, MM, and SN have no conflicts of interest. FPM is an employee of Basilea Pharmaceutica, Allschwil, Switzerland. FPM contributed to the work presented above outside of this employment. Basilea Pharmaceutica played no role in the conceptualization, conduction, or financing of this study.
